Stanislav Kononov

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Peritoneal Dialysis

Cardiovascular Risk Factors

Genome Wide Association Study

Top Venues

Pharmacogenomics

This page only lists publications with an associated author ORCID identifier.

Publications

Stanislav Kononov, Iuliia E Azarova, Elena Klyosova, Marina Bykanova, Mikhail I Churnosov, Maria Solodilova, Alexey V Polonikov
Lipid-Associated GWAS Loci Predict Antiatherogenic Effects of Rosuvastatin in Patients with Coronary Artery Disease. Genes 14 (6) (2023)
Stanislav Kononov, Iuliia E Azarova, Elena Klyosova, Marina Bykanova, Mikhail I Churnosov, Maria Solodilova, Alexey V Polonikov
Lipid-Associated GWAS Loci Predict Antiatherogenic Effects of Rosuvastatin in Patients with Coronary Artery Disease. Genes 14 (6) (2023)
Stanislav Kononov, Iuliia E Azarova, Elena Klyosova, Marina Bykanova, Mikhail I Churnosov, Maria Solodilova, Alexey V Polonikov
Lipid-Associated GWAS Loci Predict Antiatherogenic Effects of Rosuvastatin in Patients with Coronary Artery Disease. Genes 14 (6) (2023)
Victor Lazarenko, Mikhail Churilin, Iuliia E Azarova, Elena Klyosova, Marina Bykanova, Natalia Ob'edkova, Mikhail Churnosov, Olga Bushueva, Galina Mal, Sergey Povetkin, Stanislav Kononov, Yulia Luneva, Sergey Zhabin, Anna Polonikova, Alina Gavrilenko, Igor Saraev, Maria Solodilova, Alexey V Polonikov
Comprehensive Statistical and Bioinformatics Analysis in the Deciphering of Putative Mechanisms by Which Lipid-Associated GWAS Loci Contribute to Coronary Artery Disease. Biomedicines 10 (2) (2022)
Stanislav Kononov, Galina Mal, Iuliia E Azarova, Elena Y Klyosova, Marina A Bykanova, Mikhail I Churnosov, Alexey V Polonikov
Pharmacogenetic loci for rosuvastatin are associated with intima-media thickness change and coronary artery disease risk. Pharmacogenomics 23 (1) (2021)